ADVENT On Air

The latest updates in type 2 inflammatory science, brought to you by leading experts in the field. The ADVENT On Air podcast will feature scientific conversations that explore new research into the pathologies and modalities for a range of diseases linked to type 2 inflammation (atopic dermatitis, asthma, prurigo nodularis, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis). This podcast is instrumental for healthcare professionals focused on allergy, dermatology, gastroenterology, and diseases of the upper and lower airways who want to stay at the forefront of this complex, evolving disease area. Subscribe to the ADVENT On Air podcast channel to receive notifications when new episodes are released. To explore additional educational materials for HCPs about dermatology, pulmonology, rhinology, and gastroenterology, visit ADVENTprogram.com. This podcast is produced as part of ADVENT, a medical education non-promotional program organized by Sanof

ADVENT On Air is a health podcast hosted by ADVENT Program, with 17 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

ADVENT Program hosts ADVENT On Air, a health show with 17 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  ADVENT On Air

  ADVENT AD Podcast: Atopic Dermatitis: Understanding Bone Health & Growth in Pediatric Atopic Dermatitis

  Aug 17, 202617 min

  In this episode, Dr. Amy Paller and Dr. Lisa Swanson as they delve into the risk of low bone mineral density and impaired growth reported in pediatric atopic dermatitis and observed improvements in growth observed with advanced therapy, especially among children with shorter stature at baseline.   ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.   This podcast is intended for healthcare professionals only.   ·       Disclaimer: o   This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. o   The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program. o   The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits. ·       Speaker disclosures: o   Lisa Swanson, MD, FAAD, has served as an investigator for Arcutis, Castle, Organon, and Sun. Dr. Swanson has participated as a speaker for AbbVie, Arcutis, Galderma, Incyte, Johnson & Johnson, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, and Verrica. In addition, she has served as a consultant and advisory board member for AbbVie, Almirall, Alphyn, Arcutis, Boehringer Ingelheim, Castle, Chiesi, Galderma, Incyte, Johnson & Johnson, Leo, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, and Verrica. o   Amy Paller, MD, MS, has served as an advisor and consultant and has received grant funding from AbbVie, Abeona, Aegerion Pharmaceuticals, Azitra, BioCryst, Boehringer Ingelheim, Bristol Myers Squibb, Castle Creek Biosciences, Catawba, Eli Lilly and Company, Galderma, Gilead, InMed Pharmaceuticals, Janssen, Krystal Biotech, LEO Pharma, Novartis, Regeneron, Sanofi/Genzyme, Seanergy (consultant with honorarium), TWi Biotechnology, and UCB. © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2600170 – 1.0 – 07/2026    Course Descriptors:  MAT-GLB-2604085 – 1.0 – 07/2026   

  ListenShow Notes
• 

  ADVENT On Air

  ADVENT AD Podcast: Atopic Dermatitis: Understanding Bone Health & Growth in Pediatric Atopic Dermatitis

  Aug 17, 202613 min

  In this episode, Dr. Amy Paller and Dr. Lisa Swanson as they delve into the risk of low bone mineral density and impaired growth observed in pediatric atopic dermatitis.   ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.   This podcast is intended for healthcare professionals only.   ·       Disclaimer: o   This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. o   The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program. o   The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits. ·       Speaker disclosures: o   Lisa Swanson, MD, FAAD, has served as an investigator for Arcutis, Castle, Organon, and Sun. Dr. Swanson has participated as a speaker for AbbVie, Arcutis, Galderma, Incyte, Johnson & Johnson, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, and Verrica. In addition, she has served as a consultant and advisory board member for AbbVie, Almirall, Alphyn, Arcutis, Boehringer Ingelheim, Castle, Chiesi, Galderma, Incyte, Johnson & Johnson, Leo, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, and Verrica. o   Amy Paller, MD, MS, has served as an advisor and consultant and has received grant funding from AbbVie, Abeona, Aegerion Pharmaceuticals, Azitra, BioCryst, Boehringer Ingelheim, Bristol Myers Squibb, Castle Creek Biosciences, Catawba, Eli Lilly and Company, Galderma, Gilead, InMed Pharmaceuticals, Janssen, Krystal Biotech, LEO Pharma, Novartis, Regeneron, Sanofi/Genzyme, Seanergy (consultant with honorarium), TWi Biotechnology, and UCB. © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.   MAT-US-2603864 v1.0 - P Expiration Date: 07/24/2028    Course Descriptors:  MAT-US-2608354 V1.0 – P Expiration Date: 07/24/2028

  ListenShow Notes
• 

  ADVENT On Air

  More Than Just Difficulty Swallowing: Disease Burden and Diagnosis of EoE

  Jun 8, 202613 min

  Dr. Joshua Wechsler and Prof. Arjan Bredenoord discuss the burden of disease in patients with EoE, the impact on quality of life, and how to overcome challenges in identifying EoE. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. Disclaimer: This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits Speaker disclosures: Arjan Bredenoord, MD, PhD (Adult Gastroenterologist): Professor, Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, the Netherlands Joshua Wechsler, MD, MSci (Pediatric Gastroenterologist): Attending Physician, Division of Gastroenterology, Hepatology & Nutrition; Campaign Urging Research for Eosinophilic Disorders (CURED) Foundation Research Scholar; Medical Director, Eosinophilic Gastrointestinal Disorders Program; Assistant Professor in Pediatrics & Medicine, Northwestern University – The Feinberg School of Medicine © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2304791 - 2.0 - 05/2026 MAT-US-2404998 v2.0 - P Expiration Date: 05/21/2028

  ListenShow Notes
• 

  ADVENT On Air

  The Multifaceted Patient Burden and Drivers of Disease in Prurigo Nodularis

  May 7, 202629 min

  In this episode, Dr. Sarina Elmariah and Dr. Brian Kim explore prurigo nodularis (PN), with a focus on severe itch, fibrotic skin lesions, and their impact on patients’ quality of life. They discuss PN epidemiology, common comorbidities, and the challenges of managing multimorbid patients, while breaking down the neuroimmune mechanisms, highlighting the role of type 2 cytokines in itch and lesion development. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. Disclaimer: This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program. The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits. Speaker disclosures: Sarina Elmariah, MD, PhD, MPH has the following interests to disclose: Consultant, advisor, or investigator: Bambusa Therapeutics, Celldex, Disc Medicine, Galderma, Incyte, Novartis, Pfizer, Regeneron, Sanofi, ZenZema Brian Kim, MD, is co-founder of Alys Pharmaceuticals and Neurommune Therapeutics; he has served as a consultant for ABRAX Japan, AbbVie, Amgen, Attovia Therapeutics, Eli Lilly and Company, Evommune, Galderma, Gilead, LEO Pharma, Neurocrine, Novartis, Pfizer, Recens Medical, Regeneron, Sanofi, Septerna, Triveni Bio; he has stock in ABRAX Japan, Alys Pharamaceuticals, Attovia Therapeutics, Locus Biosciences, Neurommune Therapeutics, Recens Medical, and Triveni Bio. © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2504334 – 1.0 – 05/2026 MAT-US-2604824 v1.0 - P Expiration Date: 05/4/2028

  ListenShow Notes
• 

  ADVENT On Air

  Breaking the Cycle: The OCS Burden in CRSwNP

  May 6, 202614 min

  Listen to experts, Dr. Amber Luong and Dr. Marjolein Cornet, discuss the significant burden of oral corticosteroid (OCS) use in chronic rhinosinusitis with nasal polyps (CRSwNP) and its short-term, long-term, and cumulative risks, particularly for patients with coexisting conditions like asthma. Experts highlight the need for improved multidisciplinary approaches and OCS-sparing strategies to optimize patient care. ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron. This podcast is intended for healthcare professionals only. Disclaimer: This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program. The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits Speaker disclosures: Luong: Served on advisory boards for AstraZeneca, GlaxoSmithKline, Sanofi and Regeneron; Consultant to Maxwell Biosciences, Medtronic and Stryker; Grant funding from Eli Lily and Sanofi. Cornet: Marjolein Cornet has received speaker fees and participated in advisory board meetings for Regeneron Pharmaceuticals Inc., Sanofi Genzyme, GSK, ALK, Mylan, Stallergenes Greer and Medtronic. © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2601160- 1.0 - 04/2026

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.